Kolexia
Botta Danielle
Médecine générale
Hôpital La Conception
Marseille, France
86 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite C Hépatite Cirrhose du foie Hépatite C chronique Fibrose Carcinome hépatocellulaire Hépatite B Infections à VIH Hypertension artérielle

Industries

B3TSI
2 collaboration(s)
Dernière en 2021
ADVANZ PHARMA FRANCE
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Viruses   31 décembre 2022
Syndromes thalassémiques majeurs et intermédiaires
HAS Publications   29 juillet 2021
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.
European journal of clinical pharmacology   05 août 2019
Hepatitis C Virus Relapse 78 Weeks After Completion of Successful Direct-Acting Therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   01 mai 2019
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.
Journal of hepatology   06 avril 2019
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation.
Hepatology (Baltimore, Md.)   04 mars 2019
Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients.
Nephrologie & therapeutique   16 janvier 2019
Hemorrhagic transformation after stroke: inter- and intrarater agreement.
European journal of neurology   07 décembre 2018
Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study.
Transplantation   18 septembre 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.
Alimentary pharmacology & therapeutics   17 avril 2018